Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33M
-
Number of holders
-
362
-
Total 13F shares, excl. options
-
28.9M
-
Shares change
-
+384K
-
Total reported value, excl. options
-
$7.09B
-
Value change
-
+$85.1M
-
Put/Call ratio
-
2.18
-
Number of buys
-
167
-
Number of sells
-
-186
-
Price
-
$244.93
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q2 2021
435 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q2 2021.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 362 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.9M shares
of 33M outstanding shares and own 87.74% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.93M shares), VANGUARD GROUP INC (3.14M shares), WELLINGTON MANAGEMENT GROUP LLP (1.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.48M shares), JPMORGAN CHASE & CO (1.27M shares), AMERIPRISE FINANCIAL INC (1.15M shares), RIVERBRIDGE PARTNERS LLC (1.02M shares), STATE STREET CORP (824K shares), Invesco Ltd. (824K shares), and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (735K shares).
This table shows the top 362 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.